CAS: 850330-77-7
| Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
|---|---|---|---|---|
 | N-(5-(N-((3R,4R)-1-((S)-2-Aminopropanoyl)-3-methylpiperidin-4-yl)sulfamoyl)naphthalen-1-yl)-2-methylbenzamide REF: TR-A628265CAS: 850330-77-7 | - - - | 13.346,00 € | Mar 21 Ene 25 |
 | LMD-A REF: TM-T68564CAS: 850330-77-7 | - - - | 2.855,00 €~5.199,00 € | Lun 10 Mar 25 |
 | N-(5-(N-((3R,4R)-1-((S)-2-Aminopropanoyl)-3-methylpiperidin-4-yl)sulfamoyl)naphthalen-1-yl)-2-methylbenzamide REF: 3D-AJB33077CAS: 850330-77-7 | Min. 95% | - - - | Producto descatalogado |
N-(5-(N-((3R,4R)-1-((S)-2-Aminopropanoyl)-3-methylpiperidin-4-yl)sulfamoyl)naphthalen-1-yl)-2-methylbenzamide
Producto controladoCAS:850330-77-7
Fórmula:
C27H32N4O4S
Forma y color:
Neat
Peso molecular:
508.632
Ref: TR-A628265
| 100mg | 13.346,00 € |
Entrega estimada en Estados Unidos, el Martes 21 de Enero de 2025
LMD-A
CAS:850330-77-7
LMD-A, also known as CCR8 antagonist LMD-A, is a CCR8 antagonist.
Fórmula:
C27H32N4O4S
Forma y color:
Liquid
Peso molecular:
508.63
Ref: TM-T68564
| 25mg | 2.855,00 € | ||
| 50mg | 3.763,00 € | ||
| 100mg | 5.199,00 € |
Entrega estimada en Estados Unidos, el Lunes 10 de Marzo de 2025
N-(5-(N-((3R,4R)-1-((S)-2-Aminopropanoyl)-3-methylpiperidin-4-yl)sulfamoyl)naphthalen-1-yl)-2-methylbenzamide
CAS:850330-77-7
Please enquire for more information about N-(5-(N-((3R,4R)-1-((S)-2-Aminopropanoyl)-3-methylpiperidin-4-yl)sulfamoyl)naphthalen-1-yl)-2-methylbenzamide including the price, delivery time and more detailed …
Fórmula:
C27H32N4O4S
Pureza:
Min. 95%
Peso molecular:
508.6 g/mol
Ref: 3D-AJB33077
| 1mg | Descatalogado | Solicitar información | |
| 5mg | Descatalogado | Solicitar información | |
| 10mg | Descatalogado | Solicitar información | |
| 25mg | Descatalogado | Solicitar información | |
| 50mg | Descatalogado | Solicitar información |
